The documents, research papers and books below are provided for the reader to make their own informed mind up about cannabis!
|
2003
|
A Single Centre, Placebo-Controlled, Four Period, Crossover, Tolerability Study Assessing, Pharmacodynamic Effects, Pharmacokinetic Characteristics and Cognitive Profiles of a Single Dose of Three Formulations of Cannabis Based Medicine Extracts. Plus a Two Period Tolerability Study Comparing Pharmacodynamic Effects and Pharmacokinetic Characteristics of a Single Dose of a Cannabis Based Medicine Extract Given via Two Administration Routes.
|
G.W. Guy and M.E. Flint (GW Pharmaceuticals)
|
1017.pdf
(207Kb)
|
|
2003
|
A Phase I, Open Label, Four-Way Crossover Study to Compare the Pharmacokinetic Profiles of a Single Dose of 20 mg of a Cannabis Based Medicine Extract.
|
G.W. Guy and P.J. Robson (GW Pharmaceuticals)
|
1018.pdf
(216Kb)
|
|
2003
|
A Phase I, Double Blind, Three-Way Crossover Study to Assess the Pharmacokinetic Profile of Cannabis Based Medicine Extract Administered Sublingually in Variant Cannabinoid Ratios.
|
G.W. Guy and P.J. Robson (GW Pharmaceuticals)
|
1019.pdf
(149Kb)
|
|
2003
|
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study)
|
John Zajicek, Patrick Fox, Hilary Sanders, David Wright, Jane Vickery, Andrew Nunn, and Alan Thompso
|
1008.pdf
(122Kb)
|
|
2003
|
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.
|
G Pryce, Z Ahmed, D Hankley, S Jackson, JL Croxford, J Pocock, C Ledent, A Petzold, A Thompson, G Giovannoni, ML Cuzner and D Baker.
|
1013.pdf
(86Kb)
|
